Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 9 - Number 2

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

, 9(2): 113 - 131

Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti


DOI: 10.2174/187153009788452435




T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions

, 9(2): 132 - 144

Andrea Honscheid, Lothar Rink and Hajo Haase


DOI: 10.2174/187153009788452390




The AKT Axis as a Therapeutic Target in Autoimmune Diseases

, 9(2): 145 - 150

Tianfu Wu and Chandra Mohan


DOI: 10.2174/187153009788452417




Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development

, 9(2): 151 - 177

S. Rutella, G. Bonanno and R. De Cristofaro


DOI: 10.2174/187153009788452453




Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease

, 9(2): 178 - 186

S. Sergejeva and A. Linden


DOI: 10.2174/187153009788452444




Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States

, 9(2): 187 - 198

Yvonne L. Woods, John R. Petrie and Calum Sutherland


DOI: 10.2174/187153009788452408




Inflammatory Bowel Disease and Celiac Disease: Overlaps in the Pathology and Genetics, and their Potential Drug Targets

, 9(2): 199 - 218

Eleonora A.M. Festen, Agata M. Szperl, Rinse K. Weersma, Cisca Wijmenga and Martin C. Wapenaar


DOI: 10.2174/187153009788452426




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science